eli lilly glp 1 agonist Lilly's Oral GLP-1 Orforglipron Delivers in Phase III Diabetes Trial Published: April 17, 2025 @AskDrShashank Lilly's oral GLP-1 receptor agonist, orforglipron, demonstrated robust results in its first Phase III trial (ACHIEVE-1) Lilly to pour $6.5 billion
Pay in 4 interest-free payments of $5.61 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25











![Can Ozempic Cause Blood Clots? [2026 Update]](https://www.robertkinglawfirm.com/wp-content/uploads/2024/08/how-can-ozempic-cause-blood-clots.webp)














